Race Oncology Ltd (RAC) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.166x

Based on the latest financial reports, Race Oncology Ltd (RAC) has a cash flow conversion efficiency ratio of -0.166x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-6.06 Million ≈ $-4.29 Million USD) by net assets (AU$36.45 Million ≈ $25.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Race Oncology Ltd for the company's overall valuation and market capitalisation.

Race Oncology Ltd - Cash Flow Conversion Efficiency Trend (2011–2026)

This chart illustrates how Race Oncology Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Race Oncology Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Race Oncology Ltd ranked by their cash flow conversion efficiency. Explore Race Oncology Ltd (RAC) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Lionheart Holdings Unit NASDAQ:CUBWU	-0.001x
Dirui Industrial Co Ltd SHE:300396	-0.032x
Kendrion NV AS:KENDR	0.090x
Linzhou Heavy Machinery Group Co Ltd SHE:002535	0.036x
WATERDROP INC.ADS/10 CL.A F:717	N/A
YG-1 Co. Ltd KQ:019210	0.040x
Lavipharm S.A AT:LAVI	0.010x
SungEel HiTech Co. Ltd. KQ:365340	0.093x

Annual Cash Flow Conversion Efficiency for Race Oncology Ltd (2011–2026)

The table below shows the annual cash flow conversion efficiency of Race Oncology Ltd from 2011 to 2026. View Race Oncology Ltd (RAC) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-06-30	AU$36.45 Million ≈ $25.79 Million	AU$-8.25 Million ≈ $-5.83 Million	-0.226x	+20.80%
2025-06-30	AU$16.01 Million ≈ $11.33 Million	AU$-4.57 Million ≈ $-3.24 Million	-0.286x	+45.19%
2024-06-30	AU$18.31 Million ≈ $12.96 Million	AU$-9.55 Million ≈ $-6.75 Million	-0.521x	-24.73%
2023-06-30	AU$25.49 Million ≈ $18.03 Million	AU$-10.65 Million ≈ $-7.54 Million	-0.418x	-141.15%
2022-06-30	AU$36.11 Million ≈ $25.55 Million	AU$-6.26 Million ≈ $-4.43 Million	-0.173x	+49.37%
2021-06-30	AU$13.72 Million ≈ $9.71 Million	AU$-4.70 Million ≈ $-3.32 Million	-0.342x	+20.92%
2020-06-30	AU$5.69 Million ≈ $4.03 Million	AU$-2.46 Million ≈ $-1.74 Million	-0.433x	+18.25%
2019-06-30	AU$5.05 Million ≈ $3.57 Million	AU$-2.67 Million ≈ $-1.89 Million	-0.530x	-8.53%
2018-06-30	AU$7.93 Million ≈ $5.61 Million	AU$-3.87 Million ≈ $-2.74 Million	-0.488x	-11.53%
2017-06-30	AU$5.64 Million ≈ $3.99 Million	AU$-2.47 Million ≈ $-1.74 Million	-0.437x	-482.87%
2016-06-30	AU$4.08 Million ≈ $2.89 Million	AU$-306.06K ≈ $-216.56K	-0.075x	+99.59%
2015-06-30	AU$5.69K ≈ $4.02K	AU$-103.69K ≈ $-73.37K	-18.233x	-3337.39%
2014-06-30	AU$-70.24K ≈ $-49.70K	AU$-39.56K ≈ $-27.99K	0.563x	+1402.35%
2013-12-31	AU$98.97 Million ≈ $70.02 Million	AU$3.71 Million ≈ $2.63 Million	0.037x	+284.33%
2013-06-30	AU$93.38K ≈ $66.07K	AU$-1.90K ≈ $-1.34K	-0.020x	-128.73%
2012-06-30	AU$94.45 Million ≈ $66.83 Million	AU$6.68 Million ≈ $4.73 Million	0.071x	-36.42%
2011-06-30	AU$107.05 Million ≈ $75.74 Million	AU$11.92 Million ≈ $8.43 Million	0.111x	--

About Race Oncology Ltd

AU:RAC Australia Biotechnology

Market Cap

$287.17 Million

AU$405.86 Million AUD

Market Cap Rank

#15191 Global

#405 in Australia

Share Price

AU$2.07

Change (1 day)

-0.96%

52-Week Range

AU$1.93 - AU$4.70

All Time High

AU$4.70